Journal of Clinical Rheumatology

Last updated
  1. "Journal of Clinical Rheumatology". www.scimagojr.com. Retrieved 2024-02-19.

Related Research Articles

<span class="mw-page-title-main">Giant cell arteritis</span> Medical condition

Giant cell arteritis (GCA), also called temporal arteritis, is an inflammatory autoimmune disease of large blood vessels. Symptoms may include headache, pain over the temples, flu-like symptoms, double vision, and difficulty opening the mouth. Complication can include blockage of the artery to the eye with resulting blindness, as well as aortic dissection, and aortic aneurysm. GCA is frequently associated with polymyalgia rheumatica.

<span class="mw-page-title-main">Sjögren syndrome</span> Autoimmune disease affecting the bodys moisture-producing glands

Sjögren syndrome or Sjögren's syndrome is a long-term autoimmune disease that affects the body's moisture-producing glands, and often seriously affects other organ systems, such as the lungs, kidneys, and nervous system.

<span class="mw-page-title-main">Fibromyalgia</span> Chronic pain of unknown cause

Fibromyalgia is a medical condition defined by the presence of chronic widespread pain, fatigue, waking unrefreshed, cognitive symptoms, lower abdominal pain or cramps, and depression. Other symptoms include insomnia and a general hypersensitivity.

<i>Nature Reviews Rheumatology</i> Academic journal

Nature Reviews Rheumatology is a monthly peer-reviewed medical journal published by the Nature Portfolio. It was established in 2005 as Nature Clinical Practice Rheumatology and obtained its current title in 2009. The journal covers all aspects of rheumatology. The editor-in-chief is Sarah Onuora.

SAPHO syndrome includes a variety of inflammatory bone disorders that may be associated with skin changes. These diseases share some clinical, radiologic, and pathologic characteristics.

<span class="mw-page-title-main">Reactive arthritis</span> Medical condition

Reactive arthritis, also known as Reiter's syndrome, is a form of inflammatory arthritis that develops in response to an infection in another part of the body (cross-reactivity). Coming into contact with bacteria and developing an infection can trigger the disease. By the time the patient presents with symptoms, often the "trigger" infection has been cured or is in remission in chronic cases, thus making determination of the initial cause difficult.

<span class="mw-page-title-main">Tenidap</span> Chemical compound

Tenidap was a COX/5-LOX inhibitor and cytokine-modulating anti-inflammatory drug candidate that was under development by Pfizer as a promising potential treatment for rheumatoid arthritis, but Pfizer halted development after marketing approval was rejected by the FDA in 1996 due to liver and kidney toxicity, which was attributed to metabolites of the drug with a thiophene moiety that caused oxidative damage.

<span class="mw-page-title-main">Droxicam</span> NSAID analgesic drug

Droxicam is a non-steroidal anti-inflammatory drug of the oxicam class. A prodrug of piroxicam, it is used for the relief of pain and inflammation in musculoskeletal disorders such as rheumatoid arthritis and osteoarthritis.

Best Practice & Research: Clinical Rheumatology is a medical journal covering evidence-based medicine as applied to clinical practice of musculoskeletal conditions. It is aimed at clinical physicians and trainees, to help them keep up to date with current practice. Issues contain review articles with a practical bent.

<span class="mw-page-title-main">Licofelone</span> Analgesic and anti-inflammatory compound

Licofelone is a dual COX/LOX inhibitor that was studied in clinical trials as a treatment for osteoarthritis and which was under development by Merckle GmbH with partners Alfa Wassermann and Lacer.

Michael D. Lockshin is an American professor and medical researcher. He is known for his work as a researcher of autoimmune diseases, with focus on antiphospholipid syndrome and lupus. He is Professor Emeritus of Medicine and the Director Emeritus of the Barbara Volcker Center for Women and Rheumatic Disease at Hospital for Special Surgery. He retired from HSS on January 31, 2023.

<span class="mw-page-title-main">Lupus</span> Human autoimmune disease

Lupus, technically known as systemic lupus erythematosus (SLE), is an autoimmune disease in which the body's immune system mistakenly attacks healthy tissue in many parts of the body. Symptoms vary among people and may be mild to severe. Common symptoms include painful and swollen joints, fever, chest pain, hair loss, mouth ulcers, swollen lymph nodes, feeling tired, and a red rash which is most commonly on the face. Often there are periods of illness, called flares, and periods of remission during which there are few symptoms.

<i>Annals of the Rheumatic Diseases</i> Academic journal

The Annals of the Rheumatic Diseases is a monthly peer-reviewed medical journal. It is published by the BMJ Group on behalf of the European League Against Rheumatism and covers all aspects of rheumatology, including musculoskeletal conditions, arthritis, and connective tissue diseases. The journal publishes basic, clinical, and translational research, as well as abstracts from conferences. The journal was established in 1939. Each issue, the editor-in-chief selects a paper to be published open access as an "Editors Choice". The editor-in-chief is Josef Smolen.

Rontalizumab is a humanized monoclonal antibody being developed by Genentech. As of November 2009, it is being investigated in a clinical trial for the treatment of systemic lupus erythematosus.

<i>Rheumatic Disease Clinics of North America</i> Academic journal

Rheumatic Disease Clinics of North America is a medical journal addressing topics in rheumatology.

Pegsunercept is a drug for the treatment of rheumatoid arthritis. As of January 2010, Phase II clinical trials have been completed. It is being developed by Amgen.

<i>Rheumatology</i> (journal) Academic journal

Rheumatology is a monthly peer-reviewed medical journal published by Oxford University Press. It is one of two official journals of the British Society for Rheumatology, the other being Rheumatology Advances in Practice. The journal covers all aspects of paediatric and adult rheumatological conditions. The editor-in-chief is Marwan Bukhari.

Clodoveo Ferri is an Italian researcher of clinical rheumatology, immunology and internal medicine. Since January 2003, Clodoveo Ferri has been a professor of rheumatology, Chief of the Chair of Rheumatology and director of the Postgraduate School of Rheumatology at the University of Modena and Reggio Emilia in Modena, Italy. A native of Cropani, a small town in Calabria, Italy, Clodoveo Ferri graduated cum laude from the University of Pisa and later specialized in internal medicine and rheumatology.

Clinical Rheumatology is a peer-reviewed medical journal covering rheumatology. It is published by Springer Science+Business Media on behalf of the International League of Associations of Rheumatology. The journal was established in 1945 as the official journal of the Belgian Rheumatology Society and carried different titles before obtaining its current title in 1982.

The International Journal of Clinical Rheumatology is a bimonthly peer-reviewed open access medical journal. It covers rheumatology and immunology. The editor-in-chief is D.E. Furst. The journal was established in 2006 by Future Medicine under the title Future Rheumatology. It became International Journal of Clinical Rheumatology in 2009 and is now published by Open Access Journals, an imprint of the Pulsus Group, which is on Jeffrey Beall's list of "Potential, possible, or probable" predatory open-access publishers after being acquired by the OMICS Publishing Group in 2016.